Monga B.Monga B.Yearb Med Inform. 2004;(1):269-271.
.
. Am J Ther. 2021 Sep-Oct 01;28(5):e579-e580. doi: 10.1097/MJT.0000000000001443.Am J Ther. 2021.PMID: 34491955Free PMC article.
. DeVito LM, et al.Ann N Y Acad Sci. 2021 Sep 8. doi: 10.1111/nyas.14681. Online ahead of print.Ann N Y Acad Sci. 2021.PMID: 34498278
.
Impact of the Delta variant on vaccine efficacy and response strategies.
Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, Mao Q, Xu M, Liang Z.Bian L, et al.
. Haider N, et al.J Clin Invest. 2021 Sep 10:151818. doi: 10.1172/JCI151818. Online ahead of print.J Clin Invest. 2021.PMID: 34506305
.
What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?